Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03333746
Title Lenalidomide and Nivolumab in Treating Patients With Relapsed or Refractory Multiple Myeloma
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Yvonne Efebera
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.